Course Information

CPD Approved ActivityMeksi Logo

Chronic Heart Failure

Duration

3 hours

Last Updated

4/3/2025

Lessons

3 lessons

Accreditation

MEKSI Certification Available

New
Lesson 2 of 3

Step 2 – Practice learning objectives with virtual patient

Interactive Consultation Practice:

Objective: Develop and refine your consultation skills using a virtual patient interface.

Procedure:

  • Review the written segments below, that detail the case explained in the Step 1 video.
  • Formulate questions for each segment of the case.
  • Use the virtual patient interface, located on the right side of your screen, to practice your consultation skills.
  • Engage with the virtual patient by posing your formulated questions and interacting based on the provided text.
  • Note: This step is optional but highly recommended for a comprehensive understanding and hands-on experience. When you’ve finished your practice select ‘Mark Complete’ to proceed to your assessment.

Learning Objectives

By the end of this module you will be able to:

  • Identify the common risk factors for heart failure
  • Be familiar with key investigations for workup of a patient suspected to have heart failure
  • Understand the latest guidelines for managing chronic heart failure


Meet Bob


  • Bob is a 65-year-old male who is new to your GP clinic
  • He is a retired accountant and enjoys gardening in his spare time.
  • He has come to you today due to shortness of breath on exertion.


Learning Objectives - History

Bob’s history is suggestive of a chronic cardiovascular condition, as opposed to an acute or respiratory condition:

  • Symptoms gradually worsening over past 6 months
  • SOBOE, orthopnoea, reduced exercise tolerance, ankle swelling 
  • Absence of cough, sputum production, and chest tightness 

Bob has multiple risk factors for heart failure:

  • HTN, previous MI, probable undiagnosed OSA
  • Old age, male, positive family Hx for cardiac disease

Other modifiable potential risk factors:

  • Hyperlipidemia, obesity, diabetes, heavy smoking and alcohol use

Remember to ask about the patient’s  functional capacity

  • NYHA classification provides a simple way of grading functional capacity i.e. extent of heart failure
  • It provides a good marker of prognosis

Red flag conditions to keep in mind and exclude:

  • MI, pericardial disease, pulmonary embolism, aortic dissection, pneumonia


Learning Objectives - Physical Exam


  • The apex beat is laterally displaced
  • Presence of third heart sound, but no murmurs 
  • JVP likely elevated
  • Peripheral oedema up to ankles bilaterally
  • Signs of bilateral pleural effusion present


Learning Objectives - Investigations


  • Echo is key for diagnosis of heart failure
    • Measures ejection fraction to determine if pt has heart failure with reduced (<50%) or preserved (>50%) EF
    • Looks for any wall motion abnormalities 
    • Determines wall thickness and size of chambers
  • BNP/NT-proBNP can support the diagnosis and suggests disease severity
    • HF is unlikely if BNP <100 pg/ml or NT-proBNP <300 pg/ml
  • CXR can support the diagnosis and assesses for complications
    • May show characteristic signs of HF e.g. cardiomegaly
    • Complications may be present e.g. pulmonary oedema, pleural effusion
  • ECG + troponin helpful to exclude ACS
    • ECG can also exclude aF, LV hypertrophy, ongoing myocardial ischaemia or frequent ventricular ectopic beats
  • D-dimer helpful to exclude PE or acute aortic dissection
    • PE or AA dissection is unlikely if value is normal
  • Other tests are useful to screen for risk factors, causes or exacerbating factors of HF:
    • FBC (anaemia), U&Es, TFTs, fasting glucose, lipids, MSU (UTI)


Learning Objectives - Management


MEDICATIONS 

All patients with CHF should be prescribed a combination of the following regular meds:

  • ACEi e.g. ramipril; use ARB only if intolerant to ACEi e.g. candesartan
  • B-blocker e.g. metoprolol
  • Aldosterone antagonist e.g. spironolactone
  • SGLT2-inhibitor e.g. dapagliflozin

After 3 months, switch ACEi to ARNI e.g. sacubitril/valsartan (Entresto).

  • Monitor frequently for hypotension, kidney impairment, and hyperkalaemia.
  • Use diuretics (e.g. furosemide) only to treat fluid overload; reduce or cease once euvolaemia is achieved.

LIFESTYLE MODIFICATION

  • Recommend patient cut down/quit smoking and alcohol intake 
  • Restrict dietary salt intake 
  • Restrict fluid intake to 1.5L/day
  • Encourage light-moderate intensity exercise as tolerated

GENERAL ADVICE

  • Strongly advise patient to adhere to medication 
  • Poor compliance with medication is the most common cause for acute decompensated heart failure